BMI MD - Tirzepatide
bmiMD (bmimd.com) describes itself as a telehealth “managed services organization.” It states it “does not provide medical advice and does not fulfill prescription medication” directly, but facilitates online consultations with licensed physicians across all 50 states and connects patients with third-party pharmacies. Alongside compounded semaglutide, bmiMD offers compounded tirzepatide (a dual GLP-1/GIP medication) in both a standard and a lower-dose “microdose” formulation. Getting started involves an online intake form covering health history and goals, followed by what bmiMD describes as typically a same-day telehealth consultation with a board-certified physician. If approved, medication ships from a “US-based licensed partner pharmacy,” with ongoing 24/7 clinician chat access and monthly check-ins included.